[Septic shock and NO].
Mitaka
Chieko
C
Department of Critical Care Medicine, Tokyo Medical and Dental University Graduate School.
D000818:Animals; D015415:Biomarkers / Q000097:blood; D006146:Guanidines / Q000627:therapeutic use; D006162:Guanylate Cyclase; D006439:Hemodynamics; D006801:Humans; D008751:Methylene Blue / Q000627:therapeutic use; D009566:Nitrates / Q000097:blood; D009569:Nitric Oxide / Q000009:adverse effects* / Q000096:biosynthesis / Q000502:physiology*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors / Q000378:metabolism; D052247:Nitric Oxide Synthase Type II; D052250:Nitric Oxide Synthase Type III; D009573:Nitrites / Q000097:blood; D018160:Receptors, Cytoplasmic and Nuclear / Q000037:antagonists & inhibitors; D012772:Shock, Septic / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D000071756:Soluble Guanylyl Cyclase; D019323:omega-N-Methylarginine / Q000627:therapeutic use
D015415:Biomarkers; D006146:Guanidines; D009566:Nitrates; D009573:Nitrites; D018160:Receptors, Cytoplasmic and Nuclear; D019323:omega-N-Methylarginine; D009569:Nitric Oxide; C496319:NOS2 protein, human; C496314:NOS3 protein, human; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; D052250:Nitric Oxide Synthase Type III; D006162:Guanylate Cyclase; D000071756:Soluble Guanylyl Cyclase; C004479:pimagedine; D008751:Methylene Blue